SCHEMBL20205334

SCHEMBL20205334

c1ccc(-c2ccc(-c3cc4c(c5c3oc3ccccc35)-c3cc5c(cc3C43c4ccccc4-c4ccccc43)-c3c(cc(-c4ccc(-c6ccccc6)cc4)c4oc6ccccc6c34)C53c4ccccc4-c4ccccc43)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 3/20 0.37
▸ CDC14A Q9UNH5 3/20 0.37
▸ ALOX5 P09917 2/20 0.36
▸ PLA2G2A P14555 4/20 0.33
▸ PLA2G4A P47712 4/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ PDGFRB P09619 1/20 0.32
▸ KIT P10721 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA2 P00918 2/20 0.32
▸ CYP19A1 P11511 2/20 0.32
▸ GABRP O00591 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205382 0.94 CDC14B (0.34) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205339 0.93 ALOX5 (0.37) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205470 0.91 CDC14B (0.39) CDC14BCDC14AALOX5MEN1MAPT
SCHEMBL20205377 0.91 ALOX5 (0.36) CDC14BCDC14AALOX5HDAC6CA1
SCHEMBL16491777 0.90 CDC14B (0.34) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL20205655 0.89 ALOX5 (0.39) CDC14BCDC14AALOX5MEN1MAPT
SCHEMBL20205380 0.88 GPR84 (0.36) CDC14BCDC14AALOX5NPC1RAB9A
SCHEMBL20205657 0.86 ALOX5 (0.34) CDC14BCDC14AALOX5PLA2G2APLA2G4A
SCHEMBL23351579 0.86 ALOX5 (0.34) ALOX5
SCHEMBL20205665 0.86 ALOX5 (0.34) CDC14BCDC14AALOX5MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND CDC14B 3977/4885CDC14A 4435/4885ALOX5 354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback